Structure Therapeutics (GPCR) Cash & Equivalents (2022 - 2026)
Structure Therapeutics' Cash & Equivalents came in at $272.64 million for Q2 2026, up 85.4% from $147.02 million a year earlier but down 13.8% from the prior quarter.
Powered by 
Analysis
Structure Therapeutics (GPCR) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Structure Therapeutics' Cash & Equivalents was $799.62 million, up 371.7% from FY2024.
- Cash & Equivalents has increased in each of the last three years, with a three-year compound annual growth rate of 212.9% (FY2022 to FY2025).
- Going back by year, Cash & Equivalents was $169.51 million in FY2024 (+30.6%), $129.79 million in FY2023 (+397.5%) and $26.09 million in FY2022.
- The five-year range for quarterly Cash & Equivalents is $26.09 million (Q4 2022) to $799.62 million (Q4 2025).
- Year-over-year, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 98.7% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2024 (growth of 840.2%), and the weakest in Q2 2025 (a decline of 61.5%).
- Business Quant data shows GPCR's Cash & Equivalents at $316.17 million (Q1 2026), $799.62 million (Q4 2025) and $102.91 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Structure Therapeutics | 7.49 Bn | 7.49 Bn | - | 272.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 272.64 Mn |
| Mar 31, 2026 | 316.17 Mn |
| Dec 31, 2025 | 799.62 Mn |
| Sep 30, 2025 | 102.91 Mn |
| Jun 30, 2025 | 147.02 Mn |
| Mar 31, 2025 | 152.12 Mn |
| Dec 31, 2024 | 169.51 Mn |
| Sep 30, 2024 | 172.13 Mn |
| Jun 30, 2024 | 381.63 Mn |
| Mar 31, 2024 | 97.83 Mn |
| Dec 31, 2023 | 129.79 Mn |
| Sep 30, 2023 | 50.64 Mn |
| Jun 30, 2023 | 40.59 Mn |
| Mar 31, 2023 | 126.49 Mn |
| Dec 31, 2022 | 26.09 Mn |
API Access
Structure Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GPCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GPCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GPCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();